Skip to content
All Updates
- Priority Processing of Mexiletine & Systeamine Registration ApplicationJune 5, 2025
- Recall Alert: PRODUCTS DECLARED SUBSTANDARD BY PROVINCIAL DRUG TESTING LABORATORIESJune 2, 2025
- Minutes of the 347th Meeting of the Registration Board Held on 28th – 30th APRIL, 2025June 2, 2025
- Pharmacovigilance NewsletterJune 2, 2025
- Recall Alert: RECALL OF XARELTO 15MG TABLET, BATCH NO. BXK4E11, DUE TO A LABELING ERROR ON SECONDARY PACKAGINGMay 23, 2025
- Rapid Alert: CRACKDOWN AGAINST FALSIFIED/SPURIOUS DRUGSMay 22, 2025
- Stakeholders are invited to comment on Draft Guidelines on Emergency Use Authorization by 06th June, 2025May 22, 2025
- Training Session on MDMC Licensing and Product Registration Portal on: https://www.facebook.com/OfficialDRAP/May 21, 2025
- Comments are invited on revision of Guidelines on Inspection of Good Clinical Practices for Clinical TrialsMay 21, 2025
- Stakeholders Comments are invited on revision of Guidelines for Conduct of Clinical Research in PakistanMay 21, 2025
- Minutes of the 346th Meeting of the Registration Board Held on 22nd April, 2025May 21, 2025
- Rapid Alert: CRACKDOWN AGAINST FALSIFIED/SPURIOUS DRUGSMay 19, 2025
- Training of online CPI module for submission of applications(Wednesday May 21, 10:30 AM)May 19, 2025
- Minutes of 305th Meeting of the Central Licensing Board held on 24th January, 2025May 13, 2025
- Minutes of 302nd Meeting of the Central Licensing Board held on 20th November, 2024May 13, 2025
- Tender Notice for Supply & Installation of Air Conditioners, Led Tv, Multimedia Screens and Projector in DRAP HQMay 8, 2025
- Recall Alert: PRODUCTS DECLARED SUBSTANDARD BY PROVINCIAL DRUG TESTING LABORATORIESMay 7, 2025
- Recall Alert: PRODUCTS DECLARED SUBSTANDARD BY PROVINCIAL DRUG TESTING LABORATORIESMay 7, 2025
- Minutes of the 345th Meeting of the Registration Board Held on 19th to 21st February, 2025May 5, 2025
- Rapid Alert: PRESENCE OF FALSIFIED INJECTION RHOPHYLAC 300MCG, HUMAN ANTI-D IMMUNOGLOBULIN PURPORTEDLY MANUFACTURED BY M/S. CSL BEHRING AG, SWITZERLANDApril 30, 2025
- Decisions of 88th Meeting of the Medical Device BoardApril 28, 2025
- Decisions of 87th Meeting of the Medical Device BoardApril 28, 2025
- Decisions of 86th Meeting of the Medical Device BoardApril 28, 2025
- Decisions of 85th Meeting of the Medical Device BoardApril 28, 2025
- Potential Risk of Tumour Lysis Syndrome with SorafenibApril 25, 2025
- Safety Alert of Risk of persistent corneal injury and significant visual impairment with Chlorhexidine (cutaneous use)April 25, 2025
- Recall Alert: SUBSTANDARD PRODUCTS DECLARED BY DRUG TESTING LABORATORIES.April 25, 2025
- Expressions of Interest (EOI) for shortlisting of expert members of Central Licensing Board of DRAPApril 24, 2025
- Prequalification Document for Vendors/Firms through EPADS for the Supply of Services for Repair & Maintenance WorkApril 24, 2025
- Decisions of 78th Meeting of the Medical Device BoardApril 23, 2025
- Rapid Alert: CRACKDOWN AGAINST FALSIFIED / SPURIOUS DRUGSApril 22, 2025
- DRAP-PSW Gateway: Online application for Pharmaceutical export certificatesApril 21, 2025
- Bidding Document for Appointment of Tax ConsultantApril 21, 2025
- ADVISORY TO THERAPEUTIC GOODS MANUFACTURERS: MEASURES TO PREVENT DEG/EG CONTAMINATION IN ORAL LIQUID PREPARATIONSApril 21, 2025
- MDMC Data List (Local)April 21, 2025
- MDMC Data List (Import)April 21, 2025
- Recall Alert: SUBSTANDARD PRODUCTS DECLARED BY PROVINCIAL DRUG TESTING LABORATORIES.April 11, 2025
- Decisions of the Medical Device Board from 75-85th MeetingsApril 7, 2025
- Amended Drug Pricing Policy 2018April 7, 2025
- Safety Alert of Risk of severe cutaneous adverse reactions with CefotaximeApril 7, 2025
- Safety Alert risk of severe chemical irritation and damage to tissues with
Promethazine hydrochloride injectionApril 7, 2025 - Safety Alert of Risk of Drug-Induced Liver Injury (DILI) and Severe Cutaneous
Adverse Reactions (SCARs) with EzetimibeApril 7, 2025 - Safety Alert of Risk of pathological gambling with AripiprazoleApril 7, 2025
- Recall Alert: Substandard Products Declared by Provincial Drug Testing Laboratories.March 28, 2025
- Recall Alert: Substandard Products Declared by Provincial Drug Testing LaboratoriesMarch 28, 2025
- Pre-Bid Meeting Minutes and Revised Technical SpecificationMarch 28, 2025
- Disposal of Short Shelf Life CasesMarch 27, 2025
- Reports of serious adverse reactions with Ceftriaxone injection due to
unintentional mixing during reconstitution.March 24, 2025 - Safety Alert of Risk of Medication Errors resulting due to inadvertent intrathecal Tranexamic Acid InjectionMarch 20, 2025
- Notice for submission of documents by the shortlisted candidates for the recruitment of vacant positions in DRAPMarch 18, 2025